U bent hier: Rega Instituut

Rega Institute for Medical Research

Research

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C

 

 

Structural basis for protein antiaggregation activity of the trigger factor chaperone

 

 

Binding of glutathione to enterovirus capsids is essential for virion morphogenesis

 

 

Crosstalk between Sentinel and Helper Macrophages Permits Neutrophil Migration into Infected Uroepithelium

 

News

Piet Herdewijn receives Antonin Holý Memorial Lecture award

May 2014 

Wellcome Trust and KU Leuven announce collaboration with Janssen for development of dengue antiviral drugs

Aug 2013 

First antiviral drug for use in veterinary medicine has been developed by a Rega spin-off

Aug 2013 

Piet Herdewijn is awarded a prestigious ERC grant

Oct 2012 



 



 



 

Archive of selected Rega papers